The cost of treating acute promyelocytic leukemia m3 ranges from $100,000 to $500,000, depending on the degree of the disease, the individual’s physical condition, and the level of the hospital. Acute myeloid leukemia type M3 refers to acute promyelocytic leukemia, which has a good prognosis. Clinical risk stratification is often carried out, including low-risk group, intermediate-risk group and high-risk group. 1. Usually, the low and intermediate risk groups can achieve complete remission or even cure with chemotherapy such as arsenite, all-trans retinoic acid and anthracyclines (e.g. Zoerythromycin), which costs about $100,000 to $150,000. 2. The high-risk group may need hematopoietic stem cell transplantation in addition to conventional chemotherapy due to the seriousness of the disease, which is not only difficult to treat, but also costly, costing about 500,000 yuan. 3. In addition, the recovery time varies depending on the individual’s physical condition, and the longer the recovery cycle, the higher the cost. When acute promyelocytic leukemia occurs, you should actively cooperate with your doctor for standardized treatment to achieve a better prognosis.